Tactogen

Tactogen

Growth Stage

Developing new MDMA-like medicines for effective prescription mental wellness

Developing new MDMA-like medicines for effective prescription mental wellness

Overview

Raised this Round: Raised: $94,542

Total Commitments ($USD)

Platform

Wefunder

Start Date

11/10/2022

Close Date

01/31/2023

Min. Goal
$50,000
Max. Goal
$5,000,000
Min. Investment

$100

Security Type

SAFE

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$80,000,000

Discount

15%

Year Founded

2020

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B/B2C

Margin

Medium

Capital Intensity

High

Location

Palo Alto, California

Business Type

Growth

Tactogen, with a valuation of $80 million, is raising funds on Wefunder. The company is developing entactogen molecules for effective prescription mental health. Entactogens are MDMA-like molecules that help people embody a better version of themselves and let them keep their fears and self-criticism aside to think clearly about their lives. The aim of Tactogen is to bring the emotional benefits of MDMA to people while warding off their unwanted and off-target effects. Matthew Baggott founded Tactogen in February 2020. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $5 million. The campaign proceeds will be used for safety and toxicity studies for leading molecules, Phase 1 clinical trial development, and community initiatives.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-2,483,543

$-428,556

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$1,784,371

$733,443

Accounts Receivable

$8,958

$0

Total Assets

$1,799,821

$743,111

Short-Term Debt

$136,981

$55,689

Long-Term Debt

$0

$0

Total Liabilities

$136,981

$55,689

Financials as of: 11/10/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Tactogen on Wefunder 2022
Platform: Wefunder
Security Type: SAFE
Valuation: $80,000,000

Follow company

Follow Tactogen on Wefunder 2022

Buy Tactogen's Deal Report

Warning: according to the close date for this deal, Tactogen may no longer be accepting investments.

Tactogen Deal Report

Get KingsCrowd’s comprehensive report on Tactogen including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Tactogen is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Tactogen deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge